tenuigenin has been researched along with Parkinson Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, S; Fan, Z; Liu, L; Wang, X; Wei, H; Xue, F; Yang, H; Zhang, D; Zhang, W | 1 |
| Berezutsky, MA; Durnova, NA; Sigareva, LE | 1 |
| Anderson, JP; Gai, WP; Gong, XL; Halliday, G; He, Y; Huang, Y; Liang, ZG; Ren, XM; Wang, Q; Wang, X; Wang, XM; Wang, Y; Yang, J; Zhang, HB; Zheng, Y; Zhou, JX | 1 |
| Liang, Z; Lu, L; Shi, F; Wang, X; Wang, Y; Zhang, Z | 1 |
1 review(s) available for tenuigenin and Parkinson Disease
| Article | Year |
|---|---|
[Neurobiological effects of tenuigenin and the opportunity of it's using in the therapy of Alzheimer's and Parkinson's diseases (literature review).]
Topics: Alzheimer Disease; Amyloid beta-Peptides; Drugs, Chinese Herbal; Humans; Parkinson Disease | 2021 |
3 other study(ies) available for tenuigenin and Parkinson Disease
| Article | Year |
|---|---|
Tenuigenin promotes non-rapid eye movement sleep via the GABA
Topics: Animals; Electroencephalography; Eye Movements; Mice; Parkinson Disease; Receptors, GABA-A; Sleep | 2023 |
Tenuigenin attenuates α-synuclein-induced cytotoxicity by down-regulating polo-like kinase 3.
Topics: alpha-Synuclein; Cell Line, Tumor; Cell Survival; Down-Regulation; Drugs, Chinese Herbal; Humans; Parkinson Disease; Phosphorylation; Protein Serine-Threonine Kinases; Tumor Suppressor Proteins | 2013 |
Neuroprotective effects of tenuigenin in a SH-SY5Y cell model with 6-OHDA-induced injury.
Topics: Antioxidants; Cell Line, Tumor; Drugs, Chinese Herbal; Humans; Neurons; Neuroprotective Agents; Neurotoxins; Oxidopamine; Parkinson Disease | 2011 |